Meghan Holohan is a contributing writer who covers health and parenting for TODAY.com. She enjoys cooking, yoga, reading, music and walking her two rescue dogs. Follow her on Twitter to see her recent stories.
People with obesity or who are overweight and hoping to lose weight with the assistance of medication have a new option. On Nov. 8, the U.S. Food and Drug Administration approved Eli Lilly ’s weight-loss drug Zepbound , which, according to clinical trials , helped participants lose up to 52 pounds in 16 months.
Over the years, she had tried exercising and changing how she ate, but it didn’t help her lose weight. At 365 pounds, she also developed non-alcoholic fatty liver disease and insulin resistance. “I honestly had no idea how bad these things were or how much it was affecting me until the blood pressure,” the 30-year-old from Charlotte, North Carolina, told NBC News. “That was my final straw.” That’s when her doctor suggested that Mitchell take Mounjaro off-label to help her lost weight.
FDA Eli Lilly Weight-Loss Drug Zepbound Obesity Overweight Medication Clinical Trials Health Conditions High Blood Pressure Type 2 Diabetes High Cholesterol
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and WegovyBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
FDA approves new obesity drug from Eli Lilly named ZepboundThe decision by the Food and Drug Administration is expected to add to the demand for a new class of drugs transforming how patients battle obesity.
Read more »
FDA approves a new weight loss drug, Zepbound from Eli LillyThe medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
Read more »
FDA approves new version of Eli Lilly diabetes drug for weight lossThere's a unique therapy option for Hoosiers with disabilities or who are battling a mental health challenge.
Read more »
FDA approves weight loss drug from Eli Lilly that helped people lose up to 52 poundsThe U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide, which helped dieters lose up to 52 pounds in a recent study.
Read more »
FDA approves Eli Lilly's tirzepatide for weight lossEli Lilly's drug tirzepatide was approved by the Food and Drug Administration to help people who are overweight and have a weight-related medical condition lose weight.
Read more »